Ketorolac Tromethamine Injection, Solution
Product Images NDC 51662-1292

This is a description of a medication called "Ketorolac." It comes in a single-dose container that contains 1 mL. The medication is used for short-term pain relief and inflammation reduction. The container has an NDC number of 0409-3795-19, and it is manufactured by Hospira, Inc. based in Lake Forest, Illinois, USA.*

This is a description of a medication called "Ketorolac Tromethamine Inj" with the National Drug Code (NDC) of 0409-3796-19. It is a single-dose medication that comes in a 2 ml fill, with a concentration of 30 mg/mL. The manufacturer of this medication is Hospira, Inc., located in Lake Forest, IL. This medication is for "formal use only."*

Ketorolac Tromethamine Injection is a USP 30mg/mL solution available in 1mL vials. The lot number of the product is 123845, and it has an expiration date of June 30, 2030. The pH level of the solution ranges between 6.9 to 7.9, pH adjusted using Sodium Hydroxide and/or Hydrochloric acid. The solution is available for intravenous or intramuscular use and should be stored between 20 to 25°C. The usual dosage should be determined based on manufacturer instructions. Unused solution should be discarded, and it is only available through prescription. The original manufacturer's NDC code is 0409-3795-01. The product is manufactured in Mukilteo, WA, by HF Acquisition Co., LLC.*

Ketorolac Tromethamine is an injection medication that is used to relieve pain. It is sold in boxes of 25 1mL vials. It has a National Drug Code (NDC) of 51662-1292-3 and lot number 12345. The expiration date of Ketorolac Tromethamine is 2030-06-30. It is recommended to store this medication at a controlled room temperature of 20 to 25 degrees Celsius. Ketorolac Tromethamine may contain sodium hydroxide and/or hydrochloric acid for pH adjustment, and has a pH of 7.4 (6.9 to 7.9). This medication is for intravenous or intramuscular use. The usual dosage is found on the insert. The manufacturer is HF Acquisition Co., LLC, located in Mukilteo, WA 98275.*

This is a prescription drug with a manufacturer's package insert included, distributed by HF Acquisition Co., LLC in Mukilteo, WA. However, no information regarding the name or use of the drug is available from the given text.*

This is a medication with the NDC code 51662-1295-2 and Lot code ABCDEFGHIJKLMNOPQRST. It is meant for intramuscular use only and should be stored between 20 to 25°C. If not used it should be discarded. The manufacturer of this medication has an NDC code of 0409-3796-19. For more details, refer to the manufacturer's package insert. This medication is prescription-only and is distributed by the HF Acquisition Co., LLC located in Mukilteo, WA 98275.*

Ketorolac Trometham is a medication that is available in a box of 25 vials, each containing 60mg/2mL. The National Drug Code (NDC) is 51662-1295-3, the lot number is ABCDEFGHIJKLMNOPQRST, and the expiration date is June 1, 2021. The medication is intended for intramuscular use only and should be stored at temperatures ranging from 20 to 25 degrees Celsius. Any unused portion of the medication should be discarded. The manufacturer's package insert should be consulted. The medication was originally manufactured with NDC 0409-3796-19 and is distributed by HF Acquisition Co., LLC in Mukilteo, WA.*

This text describes the gastrointestinal (GI) symptoms that may be experienced, including abdominal pain, constipation, diarrhea, dyspepsia, flatulence, fullness, ulcers in the stomach or duodenum, and nausea or vomiting. It also lists other possible experiences such as abnormal renal function, anemia, dizziness, drowsiness, edema, elevated liver enzymes, headaches, hypertension, increased bleeding time, injection site pain, pruritus, purpura, rashes, tinnitus, and sweating.*

This text shows the percentage breakdown of the total daily dose of Ketorolac Tromethamine Injection in adult patients with and without a history of PUB (peptic ulcer bleeding), categorized by age and dosage amount.*

Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug used for short-term pain management in adults up to 5 days. It is not recommended for minors or chronic pain. There is a risk of gastrointestinal bleeding and/or perforation of the stomach or intestines. Therefore patients with active peptic ulcer disease, recent gastrointestinal bleeding or perforation, history of peptic ulcer disease, or gastrointestinal bleeding should not take Ketorolac tromethamine. Patients with advanced renal impairment and those at risk for renal failure due to volume depletion are also not recommended to take it. It has the potential to cause serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. It requires dosage adjustment for patients 65 years or older, for patients under 50 kg (110 Ibs.) of body weight, and for patients with moderately elevated serum creatinine. Ketorolac tromethamine tablets are only intended for continuation therapy and must not exceed 5 days combined with Ketorolac tromethamine injection.*

This text provides pharmacokinetic parameters (including bioavailability, Cmax, Tmax, Cmin, and others) for different doses (10mg, 15mg, 30mg, and 60mg) administered via oral, intramuscular, and intravenous bolus routes. The data was obtained from studies on normal volunteers and includes information on dose metabolization, excretion in urine and feces, as well as plasma protein binding. Tmax values vary depending on the dosage and administration route. Note that some data is not applicable for the 60 mg dose.*

This text presents data related to different types of subjects including normal subjects, healthy elderly subjects, patients with hepatic dysfunction or renal impairment, and renal dialysis patients. The data shows the number of subjects, mean age, and age range for each group that received intramuscular or oral administration. There is information about serum creatinine level and total clearance in L/h/kg, including the mean and range for intramuscular and oral administration. Lastly, the text displays terminal half-life in hours for oral administration with the mean and range for each group.*

Unit of Sale: This is a list of NDC codes for Ketorolac Tromethamine in 15mg/mL and 30mg/mL concentrations. They are available as single-dose glass fliptop vials in 2mL sizes. The first two codes are for trays of 25 vials each, while the third code is for an individual vial. The fourth and fifth codes are for single vials and come in trays of 25. The concentration and total fill volume of Ketorolac Tromethamine in each vial is listed in the table.*